17-35148982-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001267052.2(UNC45B):c.178G>A(p.Val60Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0481 in 1,613,820 control chromosomes in the GnomAD database, including 3,166 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_001267052.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
UNC45B | NM_001267052.2 | c.178G>A | p.Val60Ile | missense_variant | 3/20 | ENST00000394570.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
UNC45B | ENST00000394570.7 | c.178G>A | p.Val60Ile | missense_variant | 3/20 | 1 | NM_001267052.2 | P4 | |
UNC45B | ENST00000591048.2 | c.178G>A | p.Val60Ile | missense_variant | 2/17 | 1 | |||
UNC45B | ENST00000268876.9 | c.178G>A | p.Val60Ile | missense_variant | 3/20 | 5 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0500 AC: 7598AN: 152018Hom.: 333 Cov.: 32
GnomAD3 exomes AF: 0.0745 AC: 18720AN: 251342Hom.: 1352 AF XY: 0.0699 AC XY: 9489AN XY: 135844
GnomAD4 exome AF: 0.0479 AC: 69981AN: 1461684Hom.: 2832 Cov.: 31 AF XY: 0.0485 AC XY: 35234AN XY: 727162
GnomAD4 genome AF: 0.0500 AC: 7611AN: 152136Hom.: 334 Cov.: 32 AF XY: 0.0553 AC XY: 4115AN XY: 74370
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 27, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 16, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at